These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8808589)

  • 1. Efficacy of a targeted genetic screening program for adolescents.
    McCabe L
    Am J Hum Genet; 1996 Oct; 59(4):762-3. PubMed ID: 8808589
    [No Abstract]   [Full Text] [Related]  

  • 2. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.
    Mitchell JJ; Capua A; Clow C; Scriver CR
    Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical Issues with Genetic Testing for Tay-Sachs.
    Clayton T
    J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease.
    ACOG Committee on Genetics
    Obstet Gynecol; 2005 Oct; 106(4):893-4. PubMed ID: 16199656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program.
    Gason AA; Aitken M; Delatycki MB; Sheffield E; Metcalfe SA
    Genet Med; 2004; 6(4):226-31. PubMed ID: 15266211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier parents of Tay Sachs disease and beta-thalassemia.
    Shah B; Bhavsar R
    Indian Pediatr; 2005 May; 42(5):498-9. PubMed ID: 15923705
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program.
    Warren E; Anderson R; Proos AL; Burnett LB; Barlow-Stewart K; Hall J
    Genet Med; 2005 Sep; 7(7):484-94. PubMed ID: 16170240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
    Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
    J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
    [No Abstract]   [Full Text] [Related]  

  • 13. Carrier screening for Tay-Sachs disease.
    Scriver CR; Clow CL
    Lancet; 1990 Apr; 335(8693):856. PubMed ID: 1969578
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine.
    Scriver CR
    Community Genet; 2006; 9(3):142-52. PubMed ID: 16741343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic screening for ethnic minorities.
    Modell M; Modell B
    BMJ; 1990 Jun; 300(6741):1702-4. PubMed ID: 2390553
    [No Abstract]   [Full Text] [Related]  

  • 19. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic screening for reproductive purposes at school: is it a good strategy?
    Frumkin A; Zlotogora J
    Am J Med Genet A; 2008 Jan; 146A(2):264-9. PubMed ID: 18080324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.